<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
< Back to all Breaking News
BGNE
1/2/2018 06:01am
BeiGene initiates Phase 3 trial of tislelizumab

dynamic_feed Breaking News